Discover Community Create You

Loading publication...

Noodle always counts identifier-free feature events for service operation. With your permission, Google Analytics can also estimate audience and engagement. Search text, publication identifiers, cookies, IP addresses and browser fingerprints are never included in Noodle's first-party event counters.

Privacy details

Article

Conventional and emerging treatments of astrocytomas and oligodendrogliomas.

Journal of neuro-oncology - 1 May 2023

Kessler Tobias, Ito Jakob, Wick Wolfgang, Wick Antje

Abstract excerpt

PURPOSE: Astrocytomas and oligodendrogliomas are mainly diffuse primary brain tumors harboring a diagnostic and prognostically favorable isocitrate dehydrogenase mutation. They are still incurable besides growing molecular knowledge and therapy options. Circumscribed astrocytomas are also discussed here, although they represent a separate entity despite similarities in the nomenclature. METHODS: We reviewed...

Read the complete abstract on PubMed

Topics

Share this publication in a Topic to start or enrich a Post.

Share to Astrocytoma
Share to Glioma
Share to Magnetic Resonance Imaging

Methodology Data sources Editorial policy Privacy About Contact Helena Bioinformatics

Share to Mutation

Share to Oligodendroglioma

Source

Open in PubMed Open full text

Identifiers

PMID: 36566461
DOI: 10.1007/s11060-022-04216-z
PMCID: PMC10226903

Provenance

PubMed metadata and Literature Corpus relationships. Corpus snapshot updated 7 Sept 2026. Manifest publication-graph-cohort-2026-09-07.1.

Source receipt: pubmed, retrieved 7 Sept 2026.

Related research

Semantic proximity does not establish scientific evidence.

Research trail→

Click a neighbor to travelStep 1 · 12 closest

Conventional and emerging treatments of astrocytomas and oligodendrogliomas.PMID 36566461Read ↗

Anaplastic Astrocytoma: State of the art and future directions.Semantic proximity Read ↗

[Basic principles of diagnosis and treatment of gliomas].Semantic proximity Read ↗

Isocitrate dehydrogenase (IDH) mutant gliomas: A Society for Neuro-Oncology (SNO) consensus review on diagnosis, management, and future directions.Semantic proximity Read ↗

Current and promising treatment strategies in glioma.Semantic proximity Read ↗

Unlocking new horizons: advances in treating IDH-mutant, 1p/19q-codeleted oligodendrogliomasSemantic proximity Read ↗

Astrocytic gliomas WHO grades II and III.Semantic proximity Read ↗

Glioma.Semantic proximity Read ↗

Clinical features, MRI, molecular alternations, and prognosis of astrocytoma based on WHO 2021 classification of central nervous system tumors: A single-center retrospective study.Semantic proximity Read ↗

Primary brain tumours in adults.Semantic proximity Read ↗

cIMPACT-NOW update 5: recommended grading criteria and terminologies for IDH-mutant astrocytomas.Semantic proximity Read ↗

Diagnostic Approaches to Adult-Type Diffuse Glial Tumors: Comparative Literature and Clinical Practice Study.Semantic proximity Read ↗

Molecular Pathways in Gliomagenesis and Their Relevance to Neuropathologic DiagnosisSemantic proximity Read ↗

⌁Select a neighboring publication to make it the new centre.